Key Takeaways Tilray Brands shares soared 94.5% in three months, driven by strong Q1 results and investor optimism. TLRY's medical division expanded in Panama, Europe, and Australia through new launches and partnerships. TLRY Q1 net income improved to $1.5M from a $34.7M loss, reflecting cost control and operational efficiency. In the past three months, shares of Tilray Brands (TLRY) have skyrocketed 94.5%, significantly outperforming the industry’s 2.5% decline.Image Source: Zacks Investment ResearchTLRY s ...

Core Insights - The Canadian cannabis market is evolving with global demand increasing and U.S. legalization being a significant topic of interest [1][13] - Major producers are focusing on profitability, cost reduction, and high-margin opportunities like medical exports and branded products [1][13] Company Summaries Tilray Brands, Inc. (TLRY) - Tilray is expanding its U.S. presence through hemp-derived THC beverages and wellness products, focusing on consumer engagement and product innovation [3][5] - For fiscal 2025, Tilray's total net revenue increased by approximately 4% year over year to over $820 million, with gross profit in its cannabis division rising to nearly $100 million and gross margin expanding from 33% to 40% [5][12] - Despite facing a net loss due to impairment charges, management is confident in its restructuring plan and international expansion strategy [5][12] Cronos Group Inc. (CRON) - Cronos is focused on innovation and cannabinoid research, preparing for potential federal legalization in the U.S. while serving international medical and wellness markets [7][9] - In 2024, Cronos's annual net revenue rose by over 30%, with quarterly results in early 2025 showing continued progress and net income turning positive for the first time in years [9][12] - The company maintains a strong balance sheet with substantial cash reserves and minimal debt, positioning itself for sustained growth [9][12] Aurora Cannabis Inc. (ACB) - Aurora serves both medical and recreational markets across more than 25 countries, focusing on medical exports and high-quality production [10][12] - The company reported over 35% year-over-year revenue growth in 2025, with medical cannabis sales rising over 50% [12] - Aurora's strategic pivot towards the higher-margin medical market has improved profitability and stabilized cash flow, positioning it well for future growth [12][13] Industry Outlook - The Canadian cannabis sector is navigating a critical transformation period, with companies like Tilray, Cronos, and Aurora leading the charge [13][14] - Investors are encouraged to monitor technical patterns and apply strict risk management to capitalize on potential growth opportunities in November 2025 [14]

LEAMINGTON, Ontario, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced significant updates to its Tilray Medical pricing programs in Canada, reinforcing its commitment to affordability, inclusivity, and patient support. These changes are designed to make medica ...

Key Points Tilray Brands recently bought some Bitcoin, and is considering investing even more into crypto. The company's position is still fairly small in relation to other big crypto holders. Tilray continues to burn through cash, which could make it difficult for it to balance crypto purchases alongside its growth strategy. 10 stocks we like better than Tilray Brands › Tilray Brands (NASDAQ: TLRY) has struggled to get its stock price up and attract growth investors in recent years. Although it h ...

Core Insights - Cannabis stocks may experience a rally due to potential new federal regulations for hemp-derived products and a more permissive stance from President Trump on marijuana [1][4][19] Company Performance - Verano Holdings reported revenues of $203 million, a slight increase from the previous quarter but a 6% decrease year-over-year, with a net loss of $44 million attributed to impairment charges and legal contingencies [2] - Tilray Brands' stock surged 22% in October following better-than-expected fiscal first-quarter results, indicating potential for recovery in the sector [3] Market Trends - The cannabis market is projected to reach a $160 billion global market by 2032, with a 40% growth in U.S. cannabis production value last year [6] - Daily or near-daily marijuana use in the U.S. has surpassed daily drinking, reflecting increasing popularity [5] Regulatory Developments - Trump's support for Medicare coverage of CBD and potential reclassification of marijuana could attract more companies to the U.S. cannabis market [4][19] - Congress is considering updates to the 2018 Farm Bill to establish federal standards for hemp-derived products, which could enhance market legitimacy and consumer safety [13][15] Investor Sentiment - Investor optimism has surged following Trump's video promoting CBD, with significant stock price increases for companies like Tilray and Aurora Cannabis [9][11] - The cannabis industry is hopeful that federal regulations could legitimize the market and attract institutional investors [17][18] Challenges and Concerns - Despite optimism, some Republican lawmakers are pushing for stricter regulations on hemp-derived products due to safety concerns, which could impact market dynamics [24][28] - The cannabis market remains largely unregulated, leading to potential safety issues and consumer exposure to mislabeled products [15][27]

Core Insights - Tilray Brands, Inc. is expanding its craft beer offerings into Asia, specifically debuting at the American Craft Beer Experience Festival in Japan from November 22-24, 2025 [1][2] - The festival is a significant event for American craft breweries, attracting industry leaders and enthusiasts, highlighting the growing demand for premium craft beers in Asia [2][4] Company Strategy - Tilray's participation in the festival reflects its commitment to growing its beverage business in key global markets, particularly in Asia [2][4] - The company aims to enhance its international presence and engage with new audiences by showcasing its craft beer portfolio [4][5] Product Offerings - At the festival, Tilray will feature tap-only selections from its craft beer brands, including notable offerings like Cloud Mentality and Apocalypse IPA from 10 Barrel Brewing Co., West Coast IPA from Green Flash Brewing Co., and Duet IPA from Alpine Beer Company [6][4] Market Position - Tilray Brands operates as a leading global lifestyle and consumer packaged goods company, with a diverse portfolio that includes over 40 brands across more than 20 countries [5]

Core Insights - The Canadian cannabis sector is gaining renewed attention due to optimism surrounding U.S. legalization, with the U.S. cannabis industry projected to exceed $40 billion in annual sales by 2026 [1][3] - Canadian producers such as Tilray, Canopy Growth, and Village Farms are well-positioned to benefit from potential U.S. reforms that could open cross-border trade and new investment flows [1][4] - Strong consumer demand, expanding export markets, and cost-efficient production models are driving long-term growth potential in the sector [1] Company Summaries Tilray Brands, Inc. (TLRY) - Tilray reported fiscal 2025 net revenue of approximately $821 million, with cannabis revenue around $249 million, indicating a challenging competitive landscape [7] - The company's gross profit improved significantly to roughly $99 million, with gross margins expanding to nearly 40%, highlighting progress in efficiency and cost management [7] - Tilray focuses on branded products and international distribution, allowing it to operate across multiple markets beyond traditional retail cannabis [5][7] Canopy Growth Corporation (CGC) - Canopy Growth reported Canadian cannabis revenue growth of about 4% year over year, driven by rising adult-use demand [10] - The company reduced total debt by nearly 50%, although profitability remains a challenge with gross margins hovering near the mid-teens [10] - Canopy's brand-first approach positions it to benefit from potential U.S. federal reform, while ongoing restructuring efforts aim to transform operations into a more efficient, brand-driven enterprise [8][10] Village Farms International, Inc. (VFF) - Village Farms achieved revenue growth of roughly $336 million in 2024, an increase of more than 18% year over year, with the cannabis division growing 31% [13] - The company focuses on efficient production and export markets, leveraging its agricultural experience to produce high-quality cannabis [11][13] - Village Farms maintains a healthy balance sheet with modest debt levels, and its upward trend in margins makes it a compelling growth opportunity among Canadian producers [13][14]

Core Insights - Redhook Brewing, a craft brand under Tilray Brands, Inc., has launched Redhook 81, a light lager designed for post-work relaxation [1][3][4] Product Overview - Redhook 81 is a 4.2% ABV light lager with a clean flavor profile and retro can design, aimed at celebrating the end of the workday [3][4] - The beer is available in 16oz 12-packs and 4-packs at retail locations [4] Historical Context - Redhook Brewing was founded in 1981 in Seattle, playing a significant role in the craft beer movement [4][8] - The brand continues to honor its legacy by maintaining a focus on quality and community [9] Promotional Activities - A sweepstakes called the Redhook '81 Quittin' Time Kit will be launched, offering prizes for outdoor activities [5][7] - The kit includes a Redhook-branded cooler and a fly fishing rod and reel [6] Company Background - Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company involved in cannabis, beverages, and wellness [10] - The company operates in multiple regions, including North America and Europe, and supports over 40 brands [10]

We came across a bullish thesis on Tilray Brands, Inc. on Value investing subreddit by MarketFlux. In this article, we will summarize the bulls’ thesis on TLRY. Tilray Brands, Inc.'s share was trading at $2.1000 as of October 9th. TLRY’s trailing P/E was 57.50 according to Yahoo Finance. Top 20 Countries With The Highest Weed Consumption Top 20 Countries With The Highest Weed Consumption Tilray Brands (TLRY) has spent the past year executing a deliberate strategy of diversification and international exp ...

Core Viewpoint - Tilray Brands has seen a 20% increase in stock value this year, marking a significant turnaround after years of decline, driven by renewed expectations for marijuana reform in the U.S. [1][2] Company Performance - Despite the current year's positive performance, Tilray's stock has plummeted 99% over the past seven years, with a market cap dropping from nearly $42 billion in 2018 to under $2 billion today [5]. - In the most recent fiscal year ending May 31, Tilray reported net revenue of $821.3 million, a 4% year-over-year increase, although its cannabis business declined by 9% [7]. Market Conditions - The Canadian cannabis market has become saturated, while the U.S. market remains inaccessible due to federal restrictions, limiting growth opportunities for Canadian producers like Tilray [6]. - The hope for U.S. cannabis reform, including potential rescheduling from Schedule I to Schedule III, has generated optimism among investors [10]. Valuation and Investment Appeal - Tilray's current price-to-sales ratio is below 1.8, suggesting it may be undervalued, making it an attractive option for investors looking for bargains [11]. - The diversification into alcohol has provided some stability, although the cannabis segment's performance remains weak [11].